Literature DB >> 8574462

A coronary porcine organ culture system for studies of postangioplasty cell proliferation.

R Voisard1, V Jensch, R Baur, M Höher, V Hombach.   

Abstract

BACKGROUND: Restenosis after angioplasty is generally considered to be caused mainly by an increased proliferation of smooth muscle cells, but recently this theory has been questioned.
METHODS: Fresh hearts of 25 pigs were obtained and the left anterior descending coronary arteries carefully prepared, cut into segments and treated with a 3 mm standard balloon catheter for 60 s with 3, 6, 9 and 12 bar. Immediately after angioplasty the specimens were cultured in a mixture of WM/F-12, supplemented with 15% fetal calf serum.
RESULTS: After staining with a modified Verhoeff-van Gieson technique, intimal wall thickening was analysed with a computerized morphometric system. After 14 days in culture, angioplasty with 6, 9 and 12 bar resulted in a significant (P < 0.05) increase of neointimal thickening. After 21 days, a significant increase of neointimal thickening was seen after ballooning with 3, 9 or 12 bar (P < 0.05). After 28 days angioplasty with 3 or 6 bar showed a dose-dependent increase of neointima, which was not further increased after ballooning with 9 or 12 bar. Significance was reached after ballooning with 6, 9 and 12 bar (P < 0.05). Smooth muscle cells were identified with a monoclonal antibody against smooth muscle alpha-actin. Endothelial cells were identified using an anti-human von Willebrand factor. To determine the number of cells undergoing DNA synthesis, bromodeoxyuridine, a thymidine analogue, was added to the culture media 18 h before fixation. It was detected with a monoclonal antibody, with a biotinylated horse-anti-mouse antibody as secondary antibody. After 4 and 7 days in culture bromodeoxyuridine-positive cells were observed, indicating an early proliferative response after angioplasty.
CONCLUSIONS: The coronary organ culture model offers opportunities for investigations of complex cellular events that are considered important in the development of restenosis. The data reported emphasize the importance of an early proliferative response of smooth muscle cells after coronary angioplasty, resulting in a significant neointimal thickening.

Entities:  

Mesh:

Year:  1995        PMID: 8574462     DOI: 10.1097/00019501-199508000-00011

Source DB:  PubMed          Journal:  Coron Artery Dis        ISSN: 0954-6928            Impact factor:   1.439


  6 in total

1.  Combinatorial therapy of sirolimus and heparin by nanocarrier inhibits restenosis after balloon angioplasty ex vivo.

Authors:  Jayesh Betala; Sooneon Bae; Eugene M Langan; Martine LaBerge; Jeoung Soo Lee
Journal:  Nanomedicine (Lond)       Date:  2020-04-28       Impact factor: 5.307

2.  The enhanced endothelin-1-induced contraction in cultured coronary arteries from mature female pigs is not antagonized by 17beta-estradiol.

Authors:  Saigiridhar Tummala; Brent J F Hill
Journal:  Vascul Pharmacol       Date:  2006-12-09       Impact factor: 5.773

3.  3D Printed Bioreactor Enabling the Pulsatile Culture of Native and Angioplastied Large Arteries.

Authors:  Rolando S Matos; Davide Maselli; John H McVey; Christian Heiss; Paola Campagnolo
Journal:  Front Cardiovasc Med       Date:  2022-06-21

4.  The sphingosine kinase inhibitor N,N-dimethylsphingosine inhibits neointimal hyperplasia.

Authors:  Robert A McDonald; Susan Pyne; Nigel J Pyne; Anne Grant; Cherry L Wainwright; Roger M Wadsworth
Journal:  Br J Pharmacol       Date:  2009-12-15       Impact factor: 8.739

5.  Effects of mycophenolate mofetil on key pattern of coronary restenosis: a cascade of in vitro and ex vivo models.

Authors:  Rainer Voisard; Sandra Viola; Verena Kaspar; Christian M Weber; Lutz von Müller; Regine Baur; Iris Gastrock-Balitsch; Vinzenz Hombach
Journal:  BMC Cardiovasc Disord       Date:  2005-05-12       Impact factor: 2.298

6.  Simultaneous intra/extravascular administration of antiproliferative agents as a new strategy to inhibit restenosis: the peak of reactive cell proliferation as a hallmark for the duration of the treatment.

Authors:  Rainer Voisard; Eva Kucharczyk; Ute Deininger; Regine Baur; Vinzenz Hombach
Journal:  BMC Cardiovasc Disord       Date:  2002-01-18       Impact factor: 2.298

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.